1968
DOI: 10.1021/bi00841a035
|View full text |Cite
|
Sign up to set email alerts
|

Incorporation of radioactivity from labeled serotonin and tryptamine into acid-insoluble material from subcellular fractions of brain. I. Nature of the substrate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
9
0

Year Published

1971
1971
1994
1994

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 59 publications
(11 citation statements)
references
References 31 publications
2
9
0
Order By: Relevance
“…The conversion of tryptamine into ITCA reported in the present work occurs in a two-step reaction ( Fig. reaction (step 1 and step 2) at pH 7.0 which is in good agreement with the results of Alivisatos and Ungar ( 1968) for the incorporation of indoleamine into soluble material. On the other hand, we observed that step 2 of the reaction, namely the condensation of IAAL with L-cysteine, proceeds rapidly in basic media, yielding ITCA which absorbed at 276 nm.…”
Section: Discussionsupporting
confidence: 91%
See 2 more Smart Citations
“…The conversion of tryptamine into ITCA reported in the present work occurs in a two-step reaction ( Fig. reaction (step 1 and step 2) at pH 7.0 which is in good agreement with the results of Alivisatos and Ungar ( 1968) for the incorporation of indoleamine into soluble material. On the other hand, we observed that step 2 of the reaction, namely the condensation of IAAL with L-cysteine, proceeds rapidly in basic media, yielding ITCA which absorbed at 276 nm.…”
Section: Discussionsupporting
confidence: 91%
“…The rate of condensation increased on raising the pH and was unaffected by heat denaturation. Thus, the second step of the reaction showed strong similarities with the incorporation of indoleamine into nonextractable material (Alivisatos and Ungar, 1968) and with the reaction of IAAL with brain tissue observed by Nilsson and Tottmar (1985).…”
Section: Discussionsupporting
confidence: 63%
See 1 more Smart Citation
“…It may also be that any attempt to increase their overall concentrations, e.g., by inhibiting ALDH, above the detection limit of the assays presently available would only result in an increased amount of aldehyde bound to various biomolecules, and not in a higher level of free aldehyde. Such a view is supported by studies in vivo by Alivisatos and Ungar (1968), Alivisatos and Tabakoff (1973), and Alivisatos et al (1970). They injected rats or mice with ['4C]tryptamine, ['4C]tryptophan, or [I4C]5-HT and found decreased incorporation of radioactivity to brain membranes in animals given an MA0 inhibitor and increased incorporation in animals given pentobarbital or acetaldehyde, two substances capable of inhibiting the degradation of biogenic aldehydes.…”
Section: Preparation Of Biogenic Aldehydesmentioning
confidence: 90%
“…Although 5-OH-IAA itself has not previously been reported to have any regulatory role, 5-hydroxytryptamine is a neutrotransmitter (37), has been implicated in behavioral phenotypes (38)(39)(40)(41)(42)(43)(44), and is a precursor of the hormone melatonin (45). The aldehyde derived from this amine is also considered to have biological activity (46)(47)(48)(49).…”
mentioning
confidence: 99%